XXXX with normocalcemic @entity1310 . Five case reports and a review of 24 cases in the literature.

@entity1 @entity1310 @entity8 @entity5507 @entity228 @entity370 @entity617 @entity288
5 cases of @entity370 with normocalcemic @entity1310 and @entity8 are described. 24 earlier reported cases with normocalcemic @entity1310 of @entity370 were extracted from the literature and reviewed together with the present cases. GFR was normal (greater than 80 ml/min) in 2 of the @entity1 , slightly to moderately decreased (80-20 ml/min) in 14 @entity1 , and severely decreased (less than 20 ml/min) in 13 @entity1 . The @entity1 (19 males and 10 females) were 12-68 (median 45) years old. All @entity1 with GFR less than 10 ml/min were more than 43 years old. 1 @entity1 died in terminal @entity5507 on admittance. All but 1 of the @entity1 treated with @entity288 improved (22 @entity1 ) or stabilized (5 @entity1 ) at least initially. 1 @entity1 treated with a relatively low dose of a @entity228 progressed to terminal @entity5507 . 8 @entity1 had a relapse when the @entity288 were tapered or discontinued. 12 of the @entity1 had residual @entity8 after initial successful treatment and in 4 cases the impairment worsened after a @entity228 -sensitive relapse. It could be concluded from the study that an initial @entity228 dosage of 1 mg @entity617 /kg BW or more should be used in @entity1310 of @entity370 .
